http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2149429-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-06 |
| filingDate | 1993-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e539ceac89fbe25506219f9beb09141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c86068601fd82736e1a043ec22db9c80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ce44fb695ca92b374e7cbbd9f022729 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_519aebbb71e87e98023f561e854fb0f2 |
| publicationDate | 1994-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2149429-A1 |
| titleOfInvention | Aryl thiopyrano(2,3,4-c,d)indoles as inhibitors of leukotriene biosynthesis |
| abstract | Compounds having formula (I) are inhibitors of 5-lipoxygenase and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, psoriasis, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques. |
| priorityDate | 1992-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 583.